AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3969934 — intervention group
Group type: COMPARATOR
Intervention: No exercise with 3 X RDA protein intake
Number of subjects: 13
Study 30267294 — intervention group
Group type: EXPERIMENTAL
Intervention: Eluxadoline (75 mg or 100 mg)
Number of subjects: 0
Study 30267294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29257777 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffalo Concussion Treadmill Test (BCTT)
Number of subjects: 54
Study 29257777 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCTT)
Number of subjects: 54
Study 29257777 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BCTT and Control)
Number of subjects: 54
Study 29257777 — intervention group
Group type: EXPERIMENTAL
Intervention: BCTT
Number of subjects: 54
Study 27433093 — intervention group
Group type: EXPERIMENTAL
Intervention: Living liver donation (LLD)
Number of subjects: 9598
Study 27433093 — intervention group
Group type: EXPERIMENTAL
Intervention: Various factors influencing attitude toward LLD
Number of subjects: 9598
Study 24652494 — intervention group
Group type: EXPERIMENTAL
Intervention: A/California/7/2009(H1N1)-AS03 vaccine (Ad2 group)
Number of subjects: 6145
Study 24652494 — intervention group
Group type: COMPARATOR
Intervention: Nonadjuvanted A/California/7/2009(H1N1) vaccine (NAd2 group)
Number of subjects: 6145
Study 24652494 — intervention group
Group type: COMPARATOR
Intervention: A/California/7/2009(H1N1)-AS03 vaccine with saline placebo (control group)
Number of subjects: 6145
Study 22460572 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate
Number of subjects: 242
Study 22460572 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafamostat
Number of subjects: 242
Study 22460572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 20147766 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training intervention
Number of subjects: 30
Study 18049303 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 37
Study 18049303 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of telmisartan and nisoldipine
Number of subjects: 37
Study 18049303 — intervention group
Group type: COMPARATOR
Intervention: Nisoldipine
Number of subjects: 37
Study 18049303 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 37
Study 16635623 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength-training program in addition to conventional physiotherapy (PT)
Number of subjects: 39
Study 16635623 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (PT)
Number of subjects: 39
Study 12722044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin, 40 mg/d (n = 13)
Number of subjects: 26
Study 12722044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 26
Study 12722044 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study 10831023 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil HCl 5 mg for 4 weeks, followed by 10 mg for 8 weeks
Number of subjects: 17
Study 8804806 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand insertion of Copper T-380A IUD
Number of subjects: 0
Study 8804806 — intervention group
Group type: COMPARATOR
Intervention: Ring forceps insertion of Copper T-380A IUD
Number of subjects: 0
Study 1354616 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 16
Study 1354616 — intervention group
Group type: EXPERIMENTAL
Intervention: Epanolol
Number of subjects: 16
Study 1354616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6824556 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 35
Study 6824556 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 35
Study 6824556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 31748187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance (CMR) assessment during hospitalization
Number of subjects: 649
Study 31748187 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical models including Killip class >1, symptom onset-to-wire ≥6 h, LVEF≤35% using index echocardiography, and infarct size ≥40% of LV
Number of subjects: 649
Study 31748187 — intervention group
Group type: EXPERIMENTAL
Intervention: Killip class >1
Number of subjects: 649
Study 31748187 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom onset-to-wire ≥6 h
Number of subjects: 649
Study 31748187 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF≤35% using index echocardiography
Number of subjects: 649
Study 30777845 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted remote orthopedic consultations (302 consultations)
Number of subjects: 389
Study 30777845 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient consultations at the hospital (257 consultations)
Number of subjects: 389
Study 28681197 — intervention group
Group type: EXPERIMENTAL
Intervention: School support intervention (tuition, exam fees, uniform costs paid directly to schools)
Number of subjects: 835
Study 28681197 — intervention group
Group type: EXPERIMENTAL
Intervention: School support intervention
Number of subjects: 835
Study 28681197 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 835
Study 28681197 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention and Control
Number of subjects: 835
Study 25260536 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique (ligating splints to orthodontic appliances)
Number of subjects: 314
Study 25260536 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative technique (maxillomandibular screws)
Number of subjects: 314
Study 23395603 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness cues on food packages
Number of subjects: 0
Study 21555774 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered teriparatide
Number of subjects: 40
Study 21555774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20021723 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine cavity depth measured and uterocervical axis determined on day 2 or 3 of the menstrual cycle (group I)
Number of subjects: 124
Study 20021723 — intervention group
Group type: COMPARATOR
Intervention: Uterine cavity depth measured at the time of oocyte retrieval (group II)
Number of subjects: 124
Study 17189116 — intervention group
Group type: EXPERIMENTAL
Intervention: -20 cm H2O suction
Number of subjects: 29
Study 17189116 — intervention group
Group type: EXPERIMENTAL
Intervention: -10 cm H2O suction
Number of subjects: 29
Study 17189116 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater seal
Number of subjects: 29
Study 15001624 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (Te) 200 mg
Number of subjects: 13
Study 15001624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 13
Study 11689033 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D condition
Number of subjects: 0
Study 11689033 — intervention group
Group type: COMPARATOR
Intervention: 2-D condition
Number of subjects: 0
Study 9158126 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperitoneal approach
Number of subjects: 100
Study 9158126 — intervention group
Group type: COMPARATOR
Intervention: Retroperitoneal approach
Number of subjects: 100
Study 7961108 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 180 mg/m2
Number of subjects: 18
Study 7961108 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 75-180 mg/m2
Number of subjects: 18
Study 7961108 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (various doses)
Number of subjects: 18
Study 3304930 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 28
Study 3304930 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 28
Study 28831699 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-fluidics Centurion ® phacoemulsification system
Number of subjects: 164
Study 28831699 — intervention group
Group type: COMPARATOR
Intervention: Gravity-fluidics Infiniti ® Vision System
Number of subjects: 164
Study 27059990 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-flow cryocompression therapy
Number of subjects: 160
Study 27059990 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 160
Study 23907658 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline endometrial thickness greater than or equal to 5.0 mm
Number of subjects: 1272
Study 23907658 — intervention group
Group type: COMPARATOR
Intervention: Baseline endometrial thickness of 1.0-2.99 mm
Number of subjects: 1272
Study 23585513 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 142
Study 20016058 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support intervention (home visits and phone calls) for 12 months
Number of subjects: 60
Study 20016058 — intervention group
Group type: COMPARATOR
Intervention: Control group (phone number of an experienced parent, not trained to give social support)
Number of subjects: 60
Study 18070947 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell infusion with PBSCs mobilised by G-CSF
Number of subjects: 50
Study 18070947 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cell infusion)
Number of subjects: 50
Study 16174762 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan-dexamethasone
Number of subjects: 488
Study 16174762 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan
Number of subjects: 488
Study 16174762 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone alone
Number of subjects: 488
Study 16174762 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone-interferon alpha
Number of subjects: 488
Study 16174762 — intervention group
Group type: COMPARATOR
Intervention: melphalan-prednisone
Number of subjects: 488
Study 14656453 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral yohimbine (20 mg)
Number of subjects: 31
Study 14656453 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine (150 mg)
Number of subjects: 31
Study 14656453 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11092167 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient medication counseling by a clinical pharmacist prior to discharge
Number of subjects: 37
Study 11092167 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional counseling)
Number of subjects: 37
Study 9107294 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicose vein stripping
Number of subjects: 26
Study 9107294 — intervention group
Group type: COMPARATOR
Intervention: Control group (minor soft tissue trauma)
Number of subjects: 26
Study 1489941 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium citrate syrup
Number of subjects: 18
Study 1489941 — intervention group
Group type: COMPARATOR
Intervention: Lithium carbonate tablets
Number of subjects: 18
Study 1489941 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium citrate syrup and Lithium carbonate tablets
Number of subjects: 18
Study 3551524 — intervention group
Group type: EXPERIMENTAL
Intervention: Nova‐T IUD
Number of subjects: 0
Study 3551524 — intervention group
Group type: EXPERIMENTAL
Intervention: MLCu250 Short IUD
Number of subjects: 0
Study 3551524 — intervention group
Group type: EXPERIMENTAL
Intervention: MLCu375 IUD
Number of subjects: 0
Study 31840547 — intervention group
Group type: EXPERIMENTAL
Intervention: Agricultural diversification (cropping diversity, livestock ownership, cash crop production, pulses production, other vegetables production)
Number of subjects: 1006
Study 29940926 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Graded Motor Imagery (mGMI) + standard of care (SOC)
Number of subjects: 66
Study 29940926 — intervention group
Group type: COMPARATOR
Intervention: standard of care (SOC)
Number of subjects: 66
Study 29249880 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-retained mandibular overdenture
Number of subjects: 15
Study 29249880 — intervention group
Group type: COMPARATOR
Intervention: Conventional denture
Number of subjects: 15
Study 25498245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO, 1.2 g/d n‐3 LCPUFA)
Number of subjects: 105
Study 25498245 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (SO)
Number of subjects: 105
Study 25498245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO)
Number of subjects: 105
Study 25498245 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominant bacterial fragments
Number of subjects: 105
Study 22776413 — intervention group
Group type: EXPERIMENTAL
Intervention: TRC transplantation
Number of subjects: 24
Study 22776413 — intervention group
Group type: COMPARATOR
Intervention: GBR
Number of subjects: 24
Study 21044026 — intervention group
Group type: EXPERIMENTAL
Intervention: fondaparinux
Number of subjects: 127
Study 21044026 — intervention group
Group type: COMPARATOR
Intervention: enoxaparin
Number of subjects: 127
Study 19004197 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus acupoint-injection
Number of subjects: 84
Study 19004197 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of carbamazepine (Control)
Number of subjects: 84
Study 16645386 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization after 3 hours (Group A)
Number of subjects: 134
Study 16645386 — intervention group
Group type: COMPARATOR
Intervention: Mobilization after 24 hours (Group B)
Number of subjects: 134
Study 12533551 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact normothermic wound therapy
Number of subjects: 0
Study 12533551 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 0
Study 10817610 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric median nerve double-pulse stimulation (10ms and 20ms interstimulus intervals)
Number of subjects: 13
Study 10817610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathalamic SEP
Number of subjects: 13
Study 10817610 — intervention group
Group type: COMPARATOR
Intervention: Scalp SEP
Number of subjects: 13
Study 8592060 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME (25 nmol)
Number of subjects: 0
Study 8592060 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME and L-NMMA
Number of subjects: 0
Study 8592060 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME (12.5 or 25 pmol)
Number of subjects: 0
Study 8592060 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 0
Study 8592060 — intervention group
Group type: COMPARATOR
Intervention: D-NAME (25 nmol)
Number of subjects: 0
Study 8592060 — intervention group
Group type: COMPARATOR
Intervention: D-NAME and D-NMMA
Number of subjects: 0
Study 8592060 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (63 pmol)
Number of subjects: 0
Study 1346719 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg ipsapirone (IPS)
Number of subjects: 14
Study 1346719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6405427 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (200 mg)
Number of subjects: 5
Study 6405427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 31444538 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EXE) for 5 minutes after walking on a split-belt treadmill
Number of subjects: 26
Study 31444538 — intervention group
Group type: COMPARATOR
Intervention: Rest (REST) for 5 minutes after walking on a split-belt treadmill
Number of subjects: 26
Study 30350297 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeprevir
Number of subjects: 30
Study 30350297 — intervention group
Group type: EXPERIMENTAL
Intervention: Odalasvir
Number of subjects: 30
Study 30350297 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeprevir and Odalasvir (combined)
Number of subjects: 30
Study 26474714 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice training group
Number of subjects: 400
Study 26474714 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study 26474714 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete participation in the training program
Number of subjects: 400
Study 26474714 — intervention group
Group type: COMPARATOR
Intervention: Students without voice problems at baseline
Number of subjects: 400
Study 22528829 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation of attention/information processing and executive functions, 3 days/week for 12 weeks
Number of subjects: 20
Study 22528829 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group did not receive cognitive rehabilitation)
Number of subjects: 20
Study 22528829 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation of attention/information processing and executive functions
Number of subjects: 20
Study 21936735 — intervention group
Group type: EXPERIMENTAL
Intervention: PRISM-based joint protection education (PRISM-JP)
Number of subjects: 53
Study 21936735 — intervention group
Group type: COMPARATOR
Intervention: Conventional joint protection education (C-JP)
Number of subjects: 53
Study 20565458 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 16
Study 20565458 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 16
Study 20565458 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg + Lorazepam 2 mg
Number of subjects: 16
Study 20565458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17307749 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (Group I)
Number of subjects: 24
Study 17307749 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (Group II)
Number of subjects: 24
Study 17307749 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (Group I and II)
Number of subjects: 24
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 25 mg
Number of subjects: 0
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 50 mg
Number of subjects: 0
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 125 mg
Number of subjects: 0
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 300 mg
Number of subjects: 0
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 600 mg
Number of subjects: 0
Study 15827094 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (all doses)
Number of subjects: 0
Study 12072596 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (3 MU three times weekly) for 52 weeks in combination with ribavirin
Number of subjects: 116
Study 12072596 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b (3 MU three times weekly) for 52 weeks without ribavirin (placebo)
Number of subjects: 116
Study 12072596 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b with ribavirin
Number of subjects: 116
Study 12072596 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b without ribavirin (placebo)
Number of subjects: 116
Study 12072596 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 116
Study 11161866 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted vaginal hysterectomy
Number of subjects: 70
Study 11161866 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 70
Study 11161866 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall and recurrence-free survival
Number of subjects: 70
Study 9390701 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (normal ultrasound or uncomplicated hemorrhage)
Number of subjects: 53
Study 9390701 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (complicated hemorrhage or parenchymal lesions)
Number of subjects: 53
Study 9390701 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with good outcome (McCarthy General Cognitive Index score > 80)
Number of subjects: 53
Study 7955935 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (ergometer bicycling at 65% of maximal aerobic capacity)
Number of subjects: 20
Study 7955935 — intervention group
Group type: COMPARATOR
Intervention: Control (resting for 2 hours)
Number of subjects: 20
Study 3622594 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg thrice daily
Number of subjects: 14
Study 3622594 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg thrice daily
Number of subjects: 14
Study 3622594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29848836 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune-modulating nutrient-enriched enteral nutrition (EN)
Number of subjects: 34
Study 29848836 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition (EN)
Number of subjects: 34
Study 26796694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system
Number of subjects: 0
Study 26796694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23295354 — intervention group
Group type: EXPERIMENTAL
Intervention: MIM+ mentor group
Number of subjects: 28
Study 23295354 — intervention group
Group type: COMPARATOR
Intervention: MIM-only group
Number of subjects: 28
Study 23295354 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 23835818 — intervention group
Group type: EXPERIMENTAL
Intervention: MD‐Ed+A (physician education and patient activation)
Number of subjects: 712
Study 23835818 — intervention group
Group type: EXPERIMENTAL
Intervention: MD‐Ed (physician education alone)
Number of subjects: 712
Study 23835818 — intervention group
Group type: COMPARATOR
Intervention: Control (usual education)
Number of subjects: 712
Study 20601163 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention - patients complete monthly symptom surveys, and severity of symptoms is mailed to the renal provider with treatment options.
Number of subjects: 250
Study 20601163 — intervention group
Group type: EXPERIMENTAL
Intervention: Management intervention - patients complete monthly symptom surveys and are evaluated by a symptom management nurse who provides recommendations for treatment.
Number of subjects: 250